Article Information
- Received December 18, 2009
- Revision received June 18, 2010
- Accepted June 23, 2010
- First published September 1, 2010.
- Version of record published September 1, 2010.
Author Information
- 1Program in Neuroscience and
- 2Departments of Psychiatry,
- 3Biochemistry and Biophysics, and
- 4Cellular and Molecular Pharmacology, University of California at San Francisco, San Francisco, California 94158
- Correspondence should be addressed to Mark Von Zastrow, Room N212 Genentech Hall, University of California at San Francisco Mission Bay Campus, 600 16th Street, San Francisco, CA 94158-2140. mark.vonzastrow{at}ucsf.edu
Author contributions
Disclosures
- Received December 18, 2009.
- Revision received June 18, 2010.
- Accepted June 23, 2010.
-
This work was supported by research grants from the National Institutes of Health (NIH). Y.J.Y. was supported by a Kirschstein Predoctoral National Research Service Award, R.D. by a Kirschstein Postdoctoral National Research Service Award, and G.A.Y. by a K99/R00 Pathway to Independence Award from NIH—National Institute on Drug Abuse. We thank Chris Evans for valuable discussion and provision of MOR antibody and Henry Bourne, Robert Edwards, Hana El-Samad, Roger Nicoll, and members of the von Zastrow laboratory for useful discussion and critical comments. We thank Kurt Thorn and the University of California at San Francisco (UCSF) Nikon Imaging Center for critical advice and access to facilities used to carry out some of the live imaging experiments. We thank Mark Segal, Director of the UCSF Center for Bioinformatics and Molecular Biostatistics, for expert advice on statistical analysis.
- Correspondence should be addressed to Mark Von Zastrow, Room N212 Genentech Hall, University of California at San Francisco Mission Bay Campus, 600 16th Street, San Francisco, CA 94158-2140. mark.vonzastrow{at}ucsf.edu
Online Impact